Serotonergic lesions of the dorsal hippocampus differentially modulate locomotor hyperactivity induced by drugs of abuse in rats: Implications for schizophrenia

Psychopharmacology

Volumn 206, Issue 4, 2009, Pages 665-676

  Adams, Wendy ^a,b   Ayton, Scott ^a,b   Van Den Buuse, Maarten ^a,b  

^a FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

5,7 DHT; Cocaine; D Amphetamine; Drugs of abuse; Hippocampus; Ketamine; MDMA; Methamphetamine; Schizophrenia; Serotonin

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; 5 HYDROXYINDOLEACETIC ACID; 5,7 DIHYDROXYTRYPTAMINE; COCAINE; DEXAMPHETAMINE; KETAMINE; METHAMPHETAMINE; NORADRENALIN; PHENCYCLIDINE; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COCAINE DEPENDENCE; CONTROLLED STUDY; DORSAL HIPPOCAMPUS; DRUG ABUSE; HIPPOCAMPUS; HYPERACTIVITY; LOCOMOTION; MALE; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA; SEROTONIN RELEASE; SEROTONINERGIC SYSTEM; VENTRAL HIPPOCAMPUS;

5,7-DIHYDROXYTRYPTAMINE; AMPHETAMINES; ANIMALS; COCAINE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HIPPOCAMPUS; HYPERKINESIS; KETAMINE; MALE; PHENCYCLIDINE; RATS; RATS, SPRAGUE-DAWLEY; SCHIZOPHRENIA; SEROTONIN;

EID: 70349652193     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-009-1617-1     Document Type: Article

References (60)

1. A Abi-Dargham M Laruelle GK Aghajanian D Charney J Krystal 1997 The role of serotonin in the pathophysiology and treatment of schizophrenia J Neuropsychiatry Clin Neurosci 9 1 17 9017523 1:CAS:528:DyaK2sXhtVert7Y%3D
2. B Adams B Moghaddam 1998 Corticolimbic dopamine neurotransmission is temporally dissociated from the cognitive and locomotor effects of phencyclidine J Neurosci 18 5545 5554 9651235 1:CAS:528:DyaK1cXksFartLY%3D
3. W Adams S Kusljic M van den Buuse 2008 Serotonin depletion in the dorsal and ventral hippocampus: effects on locomotor hyperactivity, prepulse inhibition and learning and memory Neuropharmacology 55 1048 1055 18634810 10.1016/j.neuropharm.2008.06.035 1:CAS:528:DC%2BD1cXht1Knu7vK
4. KD Alex EA Pehek 2007 Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission Pharmacol Ther 113 296 320 17049611 10.1016/j.pharmthera.2006.08.004 1:CAS:528:DC%2BD2sXhtVCgt7Y%3D (Pubitemid 46149046)
5. M Amargos-Bosch X Lopez-Gil F Artigas A Adell 2006 Clozapine and olanzapine, but not haloperidol, suppress serotonin efflux in the medial prefrontal cortex elicited by phencyclidine and ketamine Int J Neuropsychopharmacol 9 565 573 16316487 10.1017/S1461145705005900 1:CAS:528:DC%2BD28XhtFKku73K (Pubitemid 44607209)
6. EC Azmitia 1981 Bilateral serotonergic projections to the dorsal hippocampus of the rat: simultaneous localization of 3H-5HT and HRP after retrograde transport J Comp Neurol 203 737 743 6173402 10.1002/cne.902030410 1:CAS:528:DyaL38XotVCnsA%3D%3D
7. EC Azmitia M Segal 1978 An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat J Comp Neurol 179 641 667 565370 10.1002/cne.901790311 1:STN:280:DyaE1c7ltFeguw%3D%3D
8. 2 receptors Neuropsychopharmacology 26 40 52 11751031 10.1016/S0893-133X(01)00345-1 1:CAS:528:DC%2BD3MXpt1antb0%3D (Pubitemid 34075275)
9. DS Bell 1965 Comparison of amphetamine psychosis and schizophrenia Br J Psychiatry 111 701 707 14337419 10.1192/bjp.111.477.701 1:STN:280: DyaF2M7kt1WjsQ%3D%3D
10. JP Capela M Lautenschlager U Dirnagl ML Bastos F Carvalho A Meisel 2008 5,7-Dihydroxitryptamine toxicity to serotonergic neurons in serum free raphe cultures Eur J Pharmacol 588 232 238 18519135 10.1016/j.ejphar.2008.04.046 1:CAS:528:DC%2BD1cXnt1OlurY%3D
11. RA Chambers JH Krystal DW Self 2001 A neurobiological basis for substance abuse comorbidity in schizophrenia Biol Psychiatry 50 71 83 11526998 10.1016/S0006-3223(01)01134-9 1:STN:280:DC%2BD3MvosVOjtA%3D%3D (Pubitemid 32728207)
12. EH Chartoff CL Heusner RD Palmiter 2005 Dopamine is not required for the hyperlocomotor response to NMDA receptor antagonists Neuropsychopharmacology 30 1324 1333 15688082 1:CAS:528:DC%2BD2MXlt1Kms7s%3D
13. W Danysz U Essmann I Bresink R Wilke 1994 Glutamate antagonists have different effects on spontaneous locomotor activity in rats Pharmacol Biochem Behav 48 111 118 8029281 10.1016/0091-3057(94)90506-1 1:CAS:528: DyaK2cXivFSjsbw%3D (Pubitemid 24135163)
14. HN David M Ansseau JH Abraini 2005 Dopamine-glutamate reciprocal modulation of release and motor responses in the rat caudate-putamen and nucleus accumbens of "intact" animals Brain Res Brain Res Rev 50 336 360 16278019 1:CAS:528:DC%2BD2MXht1GisbbF
15. KL Davis RS Kahn G Ko M Davidson 1991 Dopamine in schizophrenia: a review and reconceptualization Am J Psychiatry 148 1474 1486 1681750 1:STN:280:DyaK38%2Fis1GksQ%3D%3D
16. G Di Chiara A Imperato 1988 Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats Proc Natl Acad Sci U S A 85 5274 5278 2899326 10.1073/pnas.85.14. 5274 (Pubitemid 18192948)
17. GE Duncan S Miyamoto JN Leipzig JA Lieberman 1999 Comparison of brain metabolic activity patterns induced by ketamine, MK-801 and amphetamine in rats: support for NMDA receptor involvement in responses to subanesthetic dose of ketamine Brain Res 843 171 183 10528123 10.1016/S0006-8993(99)01776-X 1:CAS:528:DyaK1MXmvVGqtLo%3D (Pubitemid 29488707)
18. JH Fallon IO Opole SG Potkin 2003 The neuroanatomy of schizophrenia: circuitry and neurotransmitter systems Clin Neurosci Res 3 77 107 10.1016/S1566-2772(03)00022-7 1:CAS:528:DC%2BD3sXmsVCisLY%3D (Pubitemid 36980573)
19. NB Farber 2003 The NMDA receptor hypofunction model of psychosis Ann N Y Acad Sci 1003 119 130 14684440 10.1196/annals.1300.008 1:CAS:528: DC%2BD2cXptlGrsA%3D%3D (Pubitemid 38083050)
20. MW Feltenstein RE See 2008 The neurocircuitry of addiction: an overview Br J Pharmacol 154 261 274 18311189 10.1038/bjp.2008.51 1:CAS:528: DC%2BD1cXlvVWgu7c%3D (Pubitemid 351670601)
21. 2 receptor subtypes to the hyperlocomotor effects of cocaine: acute and chronic pharmacological analyses J Pharmacol Exp Ther 310 1246 1254 15131246 10.1124/jpet.104.068841 1:CAS:528:DC%2BD2cXnt1equ7w%3D (Pubitemid 39108947)
22. 2C receptor antagonist SB242084 on cocaine-induced locomotor activity, cocaine self-administration and cocaine-induced reinstatement of responding Neuropsychopharmacology 27 576 586 12377394 1:CAS:528:DC%2BD38Xns1Sjt7Y%3D
23. PJ Fletcher JW Chambers Z Rizos AF Chintoh 2009 Effects of 5-HT depletion in the frontal cortex or nucleus accumbens on response inhibition measured in the 5-choice serial reaction time test and on a DRL schedule Behav Brain Res 201 88 98 19428621 10.1016/j.bbr.2009.01.036 1:CAS:528:DC%2BD1MXltVCrurw%3D
24. Geyer MA, Markou A (1995) Animal models of psychiatric disorders. In: Bloom F, Kupfer D (eds) Psychopharmacology: the fourth generation of progress. Raven, New York, pp 787-798
25. Y Goto AA Grace 2008 Limbic and cortical information processing in the nucleus accumbens Trends Neurosci 31 552 558 18786735 10.1016/j.tins.2008.08.002 1:CAS:528:DC%2BD1cXht12lsbjP
26. AA Grace 2000 Gating of information flow within the limbic system and the pathophysiology of schizophrenia Brain Res Brain Res Rev 31 330 341 10719160 10.1016/S0165-0173(99)00049-1 1:STN:280:DC%2BD3c7osFGjtQ%3D%3D (Pubitemid 30136188)
27. PJ Harrison 2004 The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications Psychopharmacology (Berl) 174 151 162 10.1007/s00213-003-1761-y 1:CAS:528:DC%2BD2cXmvVahtbY%3D
28. MJ Hunt K Kessal R Garcia 2005 Ketamine induces dopamine-dependent depression of evoked hippocampal activity in the nucleus accumbens in freely moving rats J Neurosci 25 524 531 15647498 10.1523/JNEUROSCI.3800-04.2005 1:CAS:528:DC%2BD2MXptV2hsA%3D%3D (Pubitemid 40105625)
29. JD Jentsch RH Roth 1999 The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia Neuropsychopharmacology 20 201 225 10063482 10.1016/S0893-133X(98)00060-8 1:CAS:528:DyaK1MXhsleisrs%3D (Pubitemid 29067401)
30. G Jonsson 1980 Chemical neurotoxins as denervation tools in neurobiology Annu Rev Neurosci 3 169 187 6106449 10.1146/annurev.ne.03.030180.001125 1:CAS:528:DyaL3cXhslGjtrg%3D
31. DJ Kavanagh J McGrath JB Saunders G Dore D Clark 2002 Substance misuse in patients with schizophrenia: epidemiology and management Drugs 62 743 755 11929329 10.2165/00003495-200262050-00003
32. AE Kelley VB Domesick 1982 The distribution of the projection from the hippocampal formation to the nucleus accumbens in the rat: an anterograde- and retrograde-horseradish peroxidase study Neuroscience 7 2321 2335 6817161 10.1016/0306-4522(82)90198-1 1:STN:280:DyaL3s%2FovFegsA%3D%3D
33. PH Kelly SD Iversen 1976 Selective 6OHDA-induced destruction of mesolimbic dopamine neurons: abolition of psychostimulant-induced locomotor activity in rats Eur J Pharmacol 40 45 56 1033072 10.1016/0014-2999(76)90352-6 1:CAS:528:DyaE2sXltVKrtg%3D%3D
34. PH Kelly PW Seviour SD Iversen 1975 Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum Brain Res 94 507 522 1171714 10.1016/0006-8993(75)90233-4 1:CAS:528:DyaE2MXlvVygtr8%3D
35. GF Koob 1992 Drugs of abuse: anatomy, pharmacology and function of reward pathways Trends Pharmacol Sci 13 177 184 1604710 10.1016/0165-6147(92)90060-J 1:CAS:528:DyaK38XisVygsbc%3D
36. JH Krystal LP Karper JP Seibyl GK Freeman R Delaney JD Bremner GR Heninger MB Bowers Jr DS Charney 1994 Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses Arch Gen Psychiatry 51 199 214 8122957 1:CAS:528:DyaK2cXkslemtrY%3D
37. S Kusljic M van den Buuse 2004 Functional dissociation between serotonergic pathways in dorsal and ventral hippocampus in psychotomimetic drug-induced locomotor hyperactivity and prepulse inhibition in rats Eur J NeuroSci 20 3424 3432 15610175 10.1111/j.1460-9568.2004.03804.x (Pubitemid 40013552)
38. CL Littlewood N Jones MJ O'Neill SN Mitchell M Tricklebank SC Williams 2006 Mapping the central effects of ketamine in the rat using pharmacological MRI Psychopharmacology (Berl) 186 64 81 10.1007/s00213-006-0344-0 1:CAS:528:DC%2BD28XjslGisbY%3D (Pubitemid 43668312)
39. J Ma LS Leung 2000 Relation between hippocampal gamma waves and behavioral disturbances induced by phencyclidine and methamphetamine Behav Brain Res 111 1 11 10840127 10.1016/S0166-4328(00)00138-8 1:CAS:528: DC%2BD3cXjslOrt78%3D (Pubitemid 30326697)
40. J Ma SM Brudzynski LW Leung 1998 A role of subicular and hippocampal afterdischarges in initiation of locomotor activity in rats Brain Res 793 112 118 9630556 10.1016/S0006-8993(98)00165-6 1:CAS:528:DyaK1cXjsVeitb4%3D (Pubitemid 28294079)
41. AK Malhotra DA Pinals CM Adler I Elman A Clifton D Pickar A Breier 1997 Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics Neuropsychopharmacology 17 141 150 9272481 10.1016/S0893-133X(97)00036-5 1:CAS:528:DyaK2sXls1Oru7g%3D (Pubitemid 27365955)
42. 2C/2B antagonist SB 206553 on hyperactivity induced by cocaine Neuropsychopharmacology 20 556 564 10327425 10.1016/S0893-133X(98)00087-6 1:CAS:528:DyaK1MXjsVamu7o%3D (Pubitemid 29189260)
43. DR Medoff HH Holcomb AC Lahti CA Tamminga 2001 Probing the human hippocampus using rCBF: contrasts in schizophrenia Hippocampus 11 543 550 11732707 10.1002/hipo.1070 1:STN:280:DC%2BD3Mnos1agsg%3D%3D (Pubitemid 33100375)
44. GJ Mogenson DL Jones CY Yim 1980 From motivation to action: functional interface between the limbic system and the motor system Prog Neurobiol 14 69 97 6999537 10.1016/0301-0082(80)90018-0 1:STN:280:DyaL3M%2FjtlSgsQ%3D%3D (Pubitemid 10053405)
45. B Moghaddam BW Adams 1998 Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats Science 281 1349 1352 9721099 10.1126/science.281.5381.1349 1:CAS:528:DyaK1cXlvVentrw%3D
46. B Moghaddam B Adams A Verma D Daly 1997 Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex J Neurosci 17 2921 2927 9092613 1:CAS:528:DyaK2sXisValurk%3D
47. K Mukaida T Shichino S Koyanagi S Himukashi K Fukuda 2007 Activity of the serotonergic system during isoflurane anesthesia Anesth Analg 104 836 839 17377090 10.1213/01.ane.0000255200.42574.22 1:CAS:528:DC%2BD2sXjvVKisrw%3D (Pubitemid 46548305)
48. National Health and Medical Research Council of Australia (1990) Australian code of practice for the care and use of animals for scientific purposes. Australian Government Publishing Services, Canberra
49. JW Olney JW Newcomer NB Farber 1999 NMDA receptor hypofunction model of schizophrenia J Psychiatr Res 33 523 533 10628529 10.1016/S0022-3956(99)00029-1 1:STN:280:DC%2BD3c%2Fpt1Wisg%3D%3D
50. R Ortmann S Martin PC Waldmeier 1981 Supersensitivity to L-5-hydroxytryptophan after 5,7-dihydroxytryptamine injections in desmethylimipramine- and nomifensine-pretreated rats: behavioral evidence for postsynaptic supersensitivity Psychopharmacology (Berl) 74 109 114 10.1007/BF00432674 1:CAS:528:DyaL3MXkvFWmsLk%3D (Pubitemid 11126536)
51. Paxinos G, Watson C (1998) The rat brain in stereotaxic co-ordinates, 4th edn. Academic Press, San Diego
52. AJ Pijnenburg WM Honig JA Van der Heyden JM Van Rossum 1976 Effects of chemical stimulation of the mesolimbic dopamine system upon locomotor activity Eur J Pharmacol 35 45 58 3421 10.1016/0014-2999(76)90299-5 1:CAS:528: DyaE28XhtlSht7w%3D
53. RM Post 1975 Cocaine psychoses: a continuum model Am J Psychiatry 132 225 231 1115261 1:STN:280:DyaE2M7gs12itw%3D%3D
54. F Razoux R Garcia I Lena 2007 Ketamine, at a dose that disrupts motor behavior and latent inhibition, enhances prefrontal cortex synaptic efficacy and glutamate release in the nucleus accumbens Neuropsychopharmacology 32 719 727 16525415 10.1038/sj.npp.1301057 1:CAS:528:DC%2BD2sXhslWhtbY%3D (Pubitemid 46271067)
55. RB Rothman MH Baumann 2003 Monoamine transporters and psychostimulant drugs Eur J Pharmacol 479 23 40 14612135 10.1016/j.ejphar.2003.08.054 1:CAS:528:DC%2BD3sXovVGntL4%3D (Pubitemid 37377873)
56. K Semba N Adachi T Arai 2005 Facilitation of serotonergic activity and amnesia in rats caused by intravenous anesthetics Anesthesiology 102 616 623 15731601 10.1097/00000542-200503000-00021 1:CAS:528:DC%2BD2MXhsF2lurg%3D (Pubitemid 40315152)
57. JR Shoblock EB Sullivan IM Maisonneuve SD Glick 2003 Neurochemical and behavioral differences between d-methamphetamine and d-amphetamine in rats Psychopharmacology (Berl) 165 359 369 1:CAS:528:DC%2BD3sXmsFChuw%3D%3D
58. M van den Buuse B Garner A Gogos S Kusljic 2005 Importance of animal models in schizophrenia research Aust NZ J Psychiatry 39 550 557 10.1111/j.1440-1614.2005.01626.x (Pubitemid 41602539)
59. I Walaas F Fonnum 1980 Biochemical evidence for glutamate as a transmitter in hippocampal efferents to the basal forebrain and hypothalamus in the rat brain Neuroscience 5 1691 1698 6253848 10.1016/0306-4522(80)90088-3 1:CAS:528:DyaL3cXmtlKiuro%3D (Pubitemid 10005482)
60. RA Whittington L Virag 2006 Isoflurane decreases extracellular serotonin in the mouse hippocampus Anesth Analg 103 92 98 16790633 10.1213/01.ane. 0000221488.48352.61 1:CAS:528:DC%2BD28XmtVSgs7Y%3D (Pubitemid 44036039)